Home
About
Publications Trends
Recent Publications
Expert Search
Archive
post marketing surveillance
How is PMS Conducted?
Several methods are used to conduct PMS, including:
Spontaneous reporting systems
where healthcare professionals and patients report adverse events
Registry studies
that track the health outcomes of patients over time
Randomized controlled trials
and
observational studies
conducted post-approval
Electronic health records
and pharmacy databases for real-world evidence
Frequently asked queries:
What is Post Marketing Surveillance?
Why is PMS Important for Cancer Drugs?
How is PMS Conducted?
What Are the Challenges in PMS for Cancer Drugs?
What Role Do Patients Play in PMS?
What Are the Benefits of Effective PMS?
What Is the Future of PMS in Cancer Treatment?
How Effective Are Psychosocial Support Services?
What are Elevated Levels?
Can Yoga Help with Cancer-Related Fatigue?
What is Insulin Resistance?
What Challenges Exist with EHRs in Cancer Care?
What Should Cancer Patients Consider Before Aromatherapy Massage?
What are the Challenges in Read Depth Normalization?
How Effective is G-CSF in Reducing Chemotherapy-Induced Neutropenia?
What Are the Treatment Options for Incontinence in Cancer Patients?
What Types of Cancer are Most Likely to Cause Numbness?
What Are the Applications of Gene Expression Data in Cancer?
How Does Green Tea Extract Work Against Cancer?
What Are the Groundbreaking Discoveries in Cancer Research?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Nanotechnology
Non-Hodgkin’s Lymphoma
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
CIAbimatoprost
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
diffuse large B-cell lymphoma
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
Keratinocyte
Lipid-based nanoparticles
liver cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
radiotherapy
refractory lymphoma
relapsed lymphoma
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe